Reduced Burden for Oncology Patients With Decentralized Visits

Learn how our team helped implement decentralized visits for an oncology study that reduced patient burden and stress on the sites.

Oncology studies often require frequent sample collection visits. Being immunocompromised or weak from treatment poses an additional burden for travel and a rigorous day-to-day schedule for Oncology patients. Additionally, for these types of trials, frequent unscheduled safety visits are necessary but make it difficult for sites and patients to accommodate.

Read how ProPharma Group implemented decentralized trial visits to reduce the burden for patient participation as well as alleviated stress on the sites.

Case Study



The Cost of Poor Project Management

Project Management isn’t for the faint of heart. There is a shockingly high rate of project failure… but on the other hand, great project management can be a key differentiator that leads a company...


Free Webinar: Effective FDA Engagement

FDA faces challenges (like new technology) and new review models (like real world evidence) that stretch agency standards and practices. At the same time, imperatives like product safety and efficacy...


Successfully Passing MHRA Inspections for Overseas Manufacturing Sites

ProPharma Group offers GMP and GDP compliance services from clinical development to commercial distribution of the products' lifecycle. ProPharma Group’s Compliance and Quality team completed the...